Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study

Fig. 4

Comparison of the AMM qualitative profiles in serum and feces. The AMM profiles in feces and serum from the healthy subjects (n = 23), the ACI patients (survivors, n = 7; non-survivors, n = 2), and the CCI (n = 9) patients. The data are presented as the median within-group proportion of each acid among all AMM. BA benzoic acid, PhPA phenylpropionic acid, PhLA phenyllactic acid, p-HBA p-hydroxybenzoic acid, p-HPhAA p-hydroxyphenylacetic acid, p-HPhPA p-hydroxyphenylpropionic acid, HVA homovanillic acid, p-HPhLA p-hydroxyphenyllactic acid

Back to article page

Critical Care

ISSN: 1364-8535